A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for cabazitaxel.
Saved in:
| Title: | A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for cabazitaxel. |
|---|---|
| Authors: | Luo M; Department of Oncology, The Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan, China., Feng C; Department of Oncology, The Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan, China., Lin Y; Department of Oncology, The Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan, China., Chen Y; Department of Oncology, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, Sichuan, China., Pang J; Department of Oncology, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, Sichuan, China. junp@swmu.edu.cn. |
| Source: | Naunyn-Schmiedeberg's archives of pharmacology [Naunyn Schmiedebergs Arch Pharmacol] 2026 Feb; Vol. 399 (3), pp. 4547-4554. Date of Electronic Publication: 2025 Oct 23. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0326264 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1912 (Electronic) Linking ISSN: 00281298 NLM ISO Abbreviation: Naunyn Schmiedebergs Arch Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
